Programmes to encourage exercise and active lifestyles in kidney disease
| ISRCTN | ISRCTN69257140 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN69257140 |
| Secondary identifying numbers | version 1 17th March 2015 |
- Submission date
- 07/07/2015
- Registration date
- 21/08/2015
- Last edited
- 09/07/2020
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Urological and Genital Diseases
Plain English Summary
Background and study aims
People with kidney problems often suffer from a poor quality of life and many health problems. Research has shown that taking part in regular exercise can be very beneficial for their health and well-being, however we also know that few people with chronic kidney disease are being active enough. We want to explore ways to encourage patients to start being more active, at home or in their community. Other projects where researchers have worked with people with different diseases, have shown that using a self-directed approach, which includes education, goal setting and problem solving, with the support of a health-care professional has helped people start exercising regularly. This approach helped people to gain the necessary knowledge and confidence to become more active and overcome their fears or problems in order for them to keep active. This project aims to develop similar self-directed interventions for kidney patients. We have already designed a first draft version of a programme and now we want to ask patients to try it and tell us what they think. We aim to update the design of the intervention after each round of testing, based on what people tell us does or doesn’t work about the design. In this study we will invite kidney patients to take part in a self-directed physical activity programme, where we are aiming for people to increase their daily activity to a level which is suitable for them e.g. up to 30mins, 5 days per week, although we will not ask anyone to attempt exercise levels that are too much for them. At the beginning and the end of the research study we will ask the participant to complete some fitness tests and some questionnaires.
Who can participate?
Any adults with chronic kidney disease or a kidney transplant can take part in this study, as long as their own doctors consider them fit enough to participate. Participants must be able to read and understand the English language enough to give informed consent and to read the educational material supplied.
What does the study involve?
During the study, participants are asked to continue their life in the usual way. They should follow their usual recommended diet, and take their usual medicines as prescribed. Participants are asked to go to the research centre for four visits that are flexible and scheduled at their convenience. At Visit 1, they are asked to complete some simple fitness tests and fill in some questionnaires. Visit 1 takes between 1 and 3 hours. Visit 2 is the motivational counselling and education session, which takes about 1 to 3 hours. This is either delivered as a group or as an individual depending on the design of the project for testing at that point. At the session participants are given some written and illustrated material, which we go through during the session, and which is theirs to keep and take home afterwards. The session is conducted by a trained member of the research team. In the session, we talk about :
•Kidney disease and the participants health
•Exercise and physical activity and the reasons they can help to improve participants health and well-being
•How participants might use exercise and physical activity in their own lifestyle
After visit 2 participants are asked to gradually increase how much physical activity or exercise they do, for the next 6-12 weeks. They are given a pedometer to wear on the waistband of their clothing whilst they are awake. During the study, participants are asked to record how much physical activity and how many steps they do each day, and how hard it is. They are then contacted by telephone regularly throughout the intervention period to see how they are getting on. Visit 3 takes place at the end of the study period above (6-12 weeks after the counselling session). Participants are asked to repeat the same fitness tests and questionnaires that they did in Visit 1. Visit 4 is either a focus group or an individual interview, as one of the aims of the project is to hear how each participant got on throughout the study period and how we could improve it. They are asked to attend either a focus group, with other kidney patients, or an individual interview, at a mutually agreed date and time. The focus group will include about 4-8 kidney patients.
What are the possible benefits and risks of participating?
There are no direct benefits to participants of taking part in this research, although we anticipate being more physically active might help them to improve their fitness levels. We hope that the results of the study will help us design improved treatments for other kidney patients in the future. The main disadvantage of taking part is the time commitment involved in the research visits for assessments and the motivational session (4 visits, each between 1-3 hours). As with all physical activity, there is a very small risk of accident or injury during the assessment visits or whilst being physically active. All the tests will be supervised by trained research staff and will take place at a specialist research centre.
Where is the study run from?
Leicester General Hospital (UK)
When is the study starting and how long is it expected to run for?
July 2015 to July 2021
Who is funding the study?
Kidney Research UK
Who is the main contact?
Mrs Heather MacKinnon
Contact information
Public
Leicester Kidney Exercise Team
University of Leicester Acdemic Unit
Leicester General Hospital
Leicester
LE5 4PW
United Kingdom
 ORCID ID |
0000-0002-3530-0471 |
|---|---|
| Phone | +44 116 2584346 |
| hjm24@le.ac.uk |
Study information
| Study design | Single-centre interventional study |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Non randomised study |
| Study setting(s) | Hospital |
| Study type | Quality of life |
| Participant information sheet | Not available in web format, please use contact details to request a participant information sheet |
| Scientific title | Programmes to encourage Exercise and Active Lifestyles in kidney disease: a single-centre, interventional study |
| Study acronym | PEArL |
| Study hypothesis | Providing a supportive intervention, either as a group or individually, can promote self-directed physical activity in people with kidney disease and be acceptable to patients. |
| Ethics approval(s) | Research Ethics Committee (NRES Committee East Midlands - Nottingham 2), 22/5/2015, ref: 15/EM/0208 |
| Condition | Chronic kidney disease |
| Intervention | The intervention will investigate the use of both group and individual sessions to facilitate engagement in a self-directed physical activity (PA) programme. This project aims to test the intervention design; seek feedback, using semi-structured interviews; and update both the design and content based on the qualitative findings. The initial intervention design represents a 6-8 week PA programme, launched using a motivational education session, and supported by written educational material and follow-up phone calls by health care professionals. |
| Intervention type | Behavioural |
| Primary outcome measure | The primary aim of the trial is to demonstrate patient-acceptability, thus the recruitment, engagement and retention rates are the primary outcome measures. |
| Secondary outcome measures | Secondary outcome measures include a range measure of physical and functional assessments, including: 1. The Incremental and Endurance Shuttle Walk Tests, 2. Short Physical Performance Battery 3. Body composition 4. Cardiac bio-reactance A range of questionnaires will be used to measure PA levels, quality of life and symptom burden. The appropriateness of the outcome measures will be evaluated as part of the trial and will vary as indicated based on the participant feedback. |
| Overall study start date | 01/07/2015 |
| Overall study end date | 01/07/2020 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Sex | Both |
| Target number of participants | 12 |
| Participant inclusion criteria | Participants must: 1. Be >18 years of age 2. Have a diagnosis of Chronic Kidney Disease or have a kidney transplant 3. Be able to provide written consent, read the supported written material and engage in the motivational/educational session 4. Not be considered unfit by their own clinician due to physical impairment, co-morbidity or any other reason for any element of the protocol |
| Participant exclusion criteria | Participants will be excluded if: 1. <18 years of age 2. Are unable to provide written consent, read the supported written material or engage in the motivational/educational session 3. Are considered unfit by their own clinician due to physical impairment, co-morbidity or any other reason for any element of the protocol |
| Recruitment start date | 01/07/2015 |
| Recruitment end date | 01/07/2020 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
University of Leicester Academic Unit
Leicester General Hospital
Leicester
LE5 4PW
United Kingdom
Sponsor information
Hospital/treatment centre
Trust HQ, Blamoral Building Level 3, Leicester Royal Infirmary
Leicester
LE1 5WW
England
United Kingdom
| Phone | +44 116 258 4109 |
|---|---|
| RDAdmin@uhl-tr.nhs.uk | |
"ROR" |
https://ror.org/02fha3693 |
Funders
Funder type
Charity
Private sector organisation / Other non-profit organizations
- Location
- United Kingdom
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | Yes |
| IPD sharing plan summary | Available on request |
| Publication and dissemination plan | To be confirmed at a later date. |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| HRA research summary | 28/06/2023 | No | No |
Editorial Notes
09/07/2020: The trial contact details have been made publicly visible.
